12月27日(火)
● ウェアラブル・デバイス
Fitbit Withdraws Lawsuit Against Jawbone
Fitbit Withdraws Lawsuit Against Jawbone
● リウマチ・バイオシミラー
Cautious Optimism for Biosimilars in Rheumatology
Cautious Optimism for Biosimilars in Rheumatology
● 2017年・ファイザー
The 3 Biggest Risks for Pfizer in 2017
The 3 Biggest Risks for Pfizer in 2017
12月26日(月)
● メルク v. ギリアド
Will 2017 Be Gilead Sciences Inc.'s Worst Year Yet?
Will 2017 Be Gilead Sciences Inc.'s Worst Year Yet?
12月25日(日)
● ノキア v. アップル
Nokia's Second Patent Infringement Lawsuit against Apple Covers Qualcomm RF Technology, Siri and the iPhone's Design
Nokia's Second Patent Infringement Lawsuit against Apple Covers Qualcomm RF Technology, Siri and the iPhone's Design
● ウェアラブル・デバイス
Fitbit drops case to block Jawbone imports to US
Fitbit drops case to block Jawbone imports to US
12月24日(土)
● ノキア v. アップル
Part 1: Nokia Files an 8 Count Patent Infringement Case against Apple Primarily Focused on the H.264 Standard
Part 1: Nokia Files an 8 Count Patent Infringement Case against Apple Primarily Focused on the H.264 Standard
● ウェアラブル・デバイス
Fitbit Drops One Case Against Rival Jawbone
Fitbit Drops One Case Against Rival Jawbone
● 2016年のライフサイエンス訴訟
Life Science Controversies of 2016
Life Science Controversies of 2016
● 2017年の7訴訟
Seven IP Cases to Watch in Early 2017
Seven IP Cases to Watch in Early 2017
12月23日(金)
● ノキア v. アップル
Nokia Files More Patent Complaints Against Apple
Nokia Files More Patent Complaints Against Apple
● クレジットカードのセキュリティ
Federal Circuit Reverses PTAB Claim Interpretation in Dispute over Credit Card Security Patent
Federal Circuit Reverses PTAB Claim Interpretation in Dispute over Credit Card Security Patent
● メルク v. ギリアド
Merck Gilead Patent Suit: Maker Of Hepatitis C Drugs Harvoni And Sovaldi Ordered To Pay $2.54B In Royalties By Delaware Jury
Merck Gilead Patent Suit: Maker Of Hepatitis C Drugs Harvoni And Sovaldi Ordered To Pay $2.54B In Royalties By Delaware Jury
● 多発性硬化症治療薬・Copaxone
Teva sues nine companies for Copaxone patent infringement
Teva sues nine companies for Copaxone patent infringement
12月22日(木)
● ノキア v. アップル
Nokia files fresh patent lawsuits against Apple
Nokia files fresh patent lawsuits against Apple
● TCハートランド v. クラフトフーズ
Supreme Court Agrees to Hear Important Patent Venue Appeal
Supreme Court Agrees to Hear Important Patent Venue Appeal
● Prods v. Tile Tech
CAFC affirms default judgment, permanent Injunction requiring defendant to turn over mold
CAFC affirms default judgment, permanent Injunction requiring defendant to turn over mold
● サムスン v. アップル
U.S. Supreme Court Substantially Devalues Design Patent Damages on Multicomponent Products: What Design Patent Holders Need to Know
U.S. Supreme Court Substantially Devalues Design Patent Damages on Multicomponent Products: What Design Patent Holders Need to Know
● コマンドライン・インタフェース
Arista wins big in latest court patent case go-around over Cisco
Arista wins big in latest court patent case go-around over Cisco
● HCV感染治療薬・ソホスブビル
Idenix Pharmaceuticals wins $2.54 billion infringement verdict
Idenix Pharmaceuticals wins $2.54 billion infringement verdict
● プロテアソーム阻害薬・ボルテゾミブ
Millennium Pharmaceuticals sues MSN Laboratories over cancer drug
Millennium Pharmaceuticals sues MSN Laboratories over cancer drug
12月21日(水)
● マクソンリフト v. パルフィンガー
Maxon Dismisses Lawsuit Against Palfinger Liftgates
Maxon Dismisses Lawsuit Against Palfinger Liftgates
● シマンテック v. Zscaler
Cloud security vendor Zscaler bats away patent infringement lawsuit
Cloud security vendor Zscaler bats away patent infringement lawsuit
● インフィニオン v. Macom
BRIEF-Infineon says Macom has not won patent lawsuit
BRIEF-Infineon says Macom has not won patent lawsuit
● インプレッション v. レックスマーク
US Supreme Court Eyes Patent-Enforced Post-Sale Restrictions
US Supreme Court Eyes Patent-Enforced Post-Sale Restrictions
● メルク v. ギリアド
Federal jury asks Gilead to pay Merck $2.54 billion in royalties in patent infringement case
Federal jury asks Gilead to pay Merck $2.54 billion in royalties in patent infringement case
● CRISPR・ゲノム編集
Guest Post -- The Patient Side of the CRISPR Patent Battle
Guest Post -- The Patient Side of the CRISPR Patent Battle
12月20日(火)
● Pepperdata v. Yahoo
Yahoo targeted in patent suit by software developer
Yahoo targeted in patent suit by software developer
● メルク v. ギリアド
Hep C Drug Patent Dispute May Cost Gilead $7.6 Billion
Hep C Drug Patent Dispute May Cost Gilead $7.6 Billion
● アムジェン v. アポテックス
Biosimilars: New Developments in Amgen v. Apotex
Biosimilars: New Developments in Amgen v. Apotex
12月19日(月)
● ソニー v. 富士フィルム
Sony takes on Fujifilm in magnetic tape patent suit
Sony takes on Fujifilm in magnetic tape patent suit
● PNY Technologies v. Netac
BRIEF-U.S. company PNY Technologies files patent infringement lawsuit on China's Netac
BRIEF-U.S. company PNY Technologies files patent infringement lawsuit on China's Netac
12月18日(日)
12月17日(土)
● メルク v. ギリアド
Merck wins $2.54 bn in royalties in patent lawsuit
Merck wins $2.54 bn in royalties in patent lawsuit
● ウォーターエンハンサー
The Patent Case of the Decade Could End Most Patent Troll Litigation in Eastern Texas Courts against Apple & others
The Patent Case of the Decade Could End Most Patent Troll Litigation in Eastern Texas Courts against Apple & others
12月16日(金)
● コマンドライン・インタフェース
Cisco Receives Adverse Ruling Against Arista in California
Cisco Receives Adverse Ruling Against Arista in California
12月15日(木)
● サムスン v. アップル
U.S. Supreme Court Reverses Apple's Nearly $400M Verdict In Smartphone Case, But Leaves Many Questions Unresolved
U.S. Supreme Court Reverses Apple's Nearly $400M Verdict In Smartphone Case, But Leaves Many Questions Unresolved
● セキュリティ
Tech Stocks To Look Out For: Symantec Corporation (SYMC), Texas Instruments Incorporated (TXN)
Tech Stocks To Look Out For: Symantec Corporation (SYMC), Texas Instruments Incorporated (TXN)
● アムジェン・サンド・アポテックス
Solicitor General Supports Cert in Amgen v. Sandoz, Supreme Court Denies Cert in Amgen v. Apotex
Solicitor General Supports Cert in Amgen v. Sandoz, Supreme Court Denies Cert in Amgen v. Apotex
● 医薬・Colcrys(コルヒチン)
Judge revives Takeda patent lawsuit over Hikma's gout drug
Judge revives Takeda patent lawsuit over Hikma's gout drug
12月14日(水)
● サムスン v. アップル
Supreme Court Limits Design Patent Damages, Vacates Apple's $399 Million Award Against Samsung
Supreme Court Limits Design Patent Damages, Vacates Apple's $399 Million Award Against Samsung
12月13日(火)
● アムジェン・アポテックス・ニューラスタ
Supreme Court declines to hear biologic drug patent fight
Supreme Court declines to hear biologic drug patent fight
● 医薬・Oxtellar XR(オキシカルバゼピン)
Federal Circuit upholds Supernus patent victory in epilepsy drug case
Federal Circuit upholds Supernus patent victory in epilepsy drug case
● 医薬・Tikosyn(ドフェチリド)
Apicore seeks declaration of non-infringement of Pfizer’s patent
Apicore seeks declaration of non-infringement of Pfizer’s patent
● CRISPR・ゲノム編集
New Developments in CRISPR Patent Case
New Developments in CRISPR Patent Case
12月12日(月)
● アムジェン・アポテックス・ニューラスタ
Supreme Court declines to hear biologic drug patent fight
Supreme Court declines to hear biologic drug patent fight
12月11日(日)
● サムスン v. アップル
Supreme Court Takes Small Bite of Apple, Leaves Bigger Questions Aside on Design Patent Damages
Supreme Court Takes Small Bite of Apple, Leaves Bigger Questions Aside on Design Patent Damages
12月10日(土)
● グラフィックス
What Made Intel Give The Cold Shoulder To NVIDIA And Ink A Graphics Licensing Deal With AMD?
What Made Intel Give The Cold Shoulder To NVIDIA And Ink A Graphics Licensing Deal With AMD?
12月9日(金)
● グラフィックス
What Made Intel Give The Cold Shoulder To NVIDIA And Ink A Graphics Licensing Deal With AMD?
What Made Intel Give The Cold Shoulder To NVIDIA And Ink A Graphics Licensing Deal With AMD?
12月8日(木)
● 医薬・Zubsolv (ブプレノルフィン+ナロキソン)
Välinge to launch major patent infringement lawsuit in USA
Välinge to launch major patent infringement lawsuit in USA
● CRISPR・ゲノム編集
Orexo Appeal Zubsolv® US District Court Decision
Orexo Appeal Zubsolv® US District Court Decision
12月7日(水)
● サムスン v. アップル
Supreme Court Gives Samsung a Reprieve in Apple Patent Case
Supreme Court Gives Samsung a Reprieve in Apple Patent Case
12月6日(火)
● サムスン・アップル
Samsung triumphs over Apple at the Supreme Court
Samsung triumphs over Apple at the Supreme Court
● FinFET技術
Samsung Galaxy S8 Launch Delayed? Patent Lawsuit Might Affect Processor Production: Reports
Samsung Galaxy S8 Launch Delayed? Patent Lawsuit Might Affect Processor Production: Reports
● バイオシミラー・pegfilgrastim
Litigation Update: Amgen and Sandoz Stipulate to Dismiss ‘784 Patent
Litigation Update: Amgen and Sandoz Stipulate to Dismiss ‘784 Patent